1. The Defendant’s KRW 37.68 million and its relation to the Plaintiff’s KRW 6% per annum from November 15, 2019 to December 17, 2019.

1. On May 21, 2015, the Plaintiff (the name prior to the name of the Plaintiff: C) entered into an insurance solicitor D (the name prior to the name of the name) with the Defendant to enter into the “F Contract” (hereinafter “instant insurance contract”) with the insured and the beneficiary of maturity refund from May 21, 2015 through May 21, 2015 to May 21, 2030.

The insurance contract of this case includes cancer diagnosis (Renewal), cancer diagnosis (excluding small-sum cancer), cancer diagnosis (excluding small-sum cancer), (Renewal) security (not less than 20 million won), daily allowances for direct hospitalization (not less than 40 million won), cancer surgery security (200,000 won), disease surgery (Renewal), and security (200,000 won).

The Plaintiff was diagnosed at G Hospital as the main disease A, Egropia (C73), and C77. On September 30, 2019, the Plaintiff received the first-on-board occupational health care and the second-on-board occupational health care at the hospital, and received the first-on-board occupational health care in the central forest, and on November 7, 2019, filed a claim for insurance proceeds under the instant insurance contract with the Defendant. The Defendant did not pay general cancer insurance proceeds on the ground that the Plaintiff’s sick name is the first-on-board cancer, and paid the first-on-board occupational health care costs of KRW 4 million, the first-board occupational health care costs of KRW 400,00,000,000,000,000,000 won for the A-on-board occupational health care costs of KRW 20,000,00

If the plaintiff falls under general cancer, the insurance money that the defendant should pay to the plaintiff is KRW 40 million for cancer diagnosis expenses, KRW 2 million for cancer surgery expenses, KRW 100,000 for cancer hospitalization expenses, KRW 200,000 for disease surgery consolation money, KRW 42,30,000 for cancer hospitalization expenses.

The main contents of the terms and conditions relating to the instant insurance contract are as follows.

In Sub-Section 4(1) of the Insurance Terms and Conditions of this case, “Aam” refers to a disease falling under “Aams (Aams)” in the Korean Standard Disease Classification in Chapter 6.

[Attachment 2] The classification table of malicious life (C76-C80) is as shown in the attached Table 2. The classification number C77 is classified as “13. unclear, differentness, and the malicious life (C76-C80) of an unidentified father.”

[Attachment II] At the bottom.